Nomination period for the Broermann Medical Innovation Award started
Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields
Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.
The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.
The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. “With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases,” says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: “Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide.”
Nomination process and deadlines
Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.
Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org.
For further information, please contact
Broermann Medical Innovation Award
Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org
Asklepios Kliniken
Corporate Communications and Marketing
Tel.: + 49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com
24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888
Visit Asklepios on the Internet, Facebook or YouTube:
www.asklepios.com
www.asklepios.com/konzern/gesundheitsmagazin
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken
RHÖN-KLINIKUM AG
Corporate Communications and Marketing
Heike Ochmann
Press Spokeswoman
Tel.: +49 (0) 9771 / 65-12130
E-Mail: heike.ochmann@rhoen-klinikum-ag.com
MEDICLIN AG
Dr. Janina Lossen
Press Spokeswoman
Tel:. +49 (0) 781 / 488-180
E-Mail: presse@mediclin.de
UKGM
Frank Steibli
Head of Communications and Press Spokesman
Tel.: +49 (0) 641 / 985-51020
Mobile: +49 (0) 160 / 7120456
E-Mail: frank.steibli@uk-gm.de
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 16:00:00 CET | Press release
Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”
SKYLOTEC announces planned integration of LIBERVIT SAS to expand tactical access solutions18.11.2025 14:38:44 CET | Press release
Neuwied, 18 November 2025 – SKYLOTEC, a global leader in fall protection, rescue equipment, and tactical access solutions, has reached an agreement to integrate the French company LIBERVIT SAS. Through this planned integration, SKYLOTEC will expand its portfolio to include hydraulic breaching tools for Military, Law Enforcement, Fire & Rescue and industrial applications. This step continues the company’s growth strategy in the LEAF segment (Law Enforcement and Armed Forces) and reinforces its position as a World Leader in Tactical Access.
ELATEC Introduces DevPack 5.07: A Major Leap Forward in RFID Reader Management and Mobile Integration18.11.2025 11:07:07 CET | Press release
(Puchheim, Germany) ELATEC, a leading manufacturer of access technologies, specializing in RFID readers and credentials, has released its latest software development toolkit, TWN4 DevPack 5.07. The new version delivers faster performance, stronger security and greater flexibility for configuring and managing RFID readers, enabling flexible and future-proof access solutions. “With every DevPack release, our goal is to make life easier for developers, system integrators and end users,” said Tobias Rasche, Global Head of Product Management of ELATEC GmbH. “Version 5.07 takes another big step forward by combining deeper diagnostics, broader mobile credential support and open-standard interoperability, all in one powerful package. With this evolution, our DevPack is now more than a development toolkit—it’s a comprehensive framework for building secure, flexible, and future-ready authentication solutions.” Future-Proof Mobile and Security Capabilities DevPack 5.07 expands ELATEC’s support fo
LEIPZIG BACH ARCHIVE PRESENTS NEWLY DISCOVERED ORGAN WORKS BY JOHANN SEBASTIAN BACH17.11.2025 16:00:00 CET | Press release
Leipzig-based Bach researcher Peter Wollny identifies two organ compositions as the work of the 18-year-old Johann Sebastian Bach · First performance in 320 years to be livestreamed from St Thomas’ Church, Leipzig
European Network for Technological Resilience and Sovereignty (ETRS) to strengthen Europe’s Digital Future17.11.2025 10:00:00 CET | Press release
On the eve of the Summit on European Digital Sovereignty in Berlin, leading European think tanks and experts announce the creation of the European Network for Technological Resilience and Sovereignty (ETRS). This new initiative unites research, policy, and industry to boost Europe’s capacity for innovation and independence in key technologies like AI, cloud infrastructure, and semiconductors. ETRS aims to build the evidence base, foster collaboration, and shape policy for a resilient and values-driven digital future.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom